As Pharmacy Technician Day approaches, the CEO of the Pharmacy Technician Certification Board argues that real recognition means career ladders, consistent scope regulations, and investment in certification.
|Articles|February 1, 2005
- Volume 0 0
Pharmacies Donate Funds for Tsunami Victims
Advertisement
Rite Aid and the CVS/pharmacyCharitable Trust are launching campaignsto help the victims, families,and communities affected by thetsunami disaster in Asia. The Rite AidFoundation is making a $50,000 donationto the American Red Cross InternationalRelief Fund for Tsunami reliefefforts. In addition, customers candonate funds by purchasing $1 disasterrelief certificates at any Rite Aidstore across the United States.
The CVS/pharmacy and CharitableTrust is donating $1 million to theAmerican Red Cross to help with reliefefforts. Furthermore, the trust haspledged to match up to $500,000 indonor contributions nationwide to theAmerican Red Cross InternationalResponse Fund.
Articles in this issue
over 21 years ago
Issues in the Treatment of Patients with Hypothyroidismover 21 years ago
Health Organizations Favor Electronic Health Recordsover 21 years ago
Therapeutic Management of Bronchitisover 21 years ago
Program Advocates for Timely Prescription Refillsover 21 years ago
Cardinal Backs RFID Technologyover 21 years ago
Agreement Improves Point of Careover 21 years ago
Decision Unpopular with Health Care Professionalsover 21 years ago
The Importance of the Order of Drug Administrationover 21 years ago
Beware of Erroneous Daily Oral Methotrexate Dosing!Advertisement
Related to this article
William J. Peppard, PharmD, explains how emerging suzetrigine findings after knee arthroplasty connect opioid stewardship with functional recovery and the pharmacist’s role in ensuring treatment access.
Tor Härnqvist, MD, discusses immune testing after invasive pneumococcal disease, serotype-informed vaccine selection, and pharmacists' role in supporting patients on immunoglobulin therapy.
In adults with type 2 diabetes at high cardiovascular (CV) risk, the oral GLP-1 RA also improved HbA1C and weight, with less hypoglycemia but more GI events.
In an interview with Pharmacy Times, LINKER-SMM1 study investigator Paula Rodríguez-Otero, MD, PhD, a hematologist at Clínica Universidad de Navarra in Pamplona, Spain, explains how researchers selected high-risk patients and how she weighs infections against the potential to prevent progression to active disease.
BRUIN CLL-313 showed significantly longer progression-free survival vs bendamustine plus rituximab, bringing a noncovalent BTK inhibitor to first-line care.
A behavioral walking program matched supervised aerobic training for improving asthma control in a randomized trial of physically inactive adults.
Phase 2b data from EASD 2026 show the amylin-incretin combination also cut HbA1C by up to 2.9% in adults with obesity or overweight and type 2 diabetes.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Butter, Beef Tallow, and LDL: Where Dietary Guidelines Diverge
2
Why Patients Fear Statins Will Affect Their Memory
3
Orforglipron Shows CV Safety vs Insulin Glargine in ACHIEVE-4
4
Suzetrigine After Knee Replacement: Are Fewer Opioid Prescriptions Enough?
5